Innocan Pharma
InnoCan aims to harness the power of cannabinoids to target a wide variety of health problems. InnoCan plans to initially innovate new dermatology treatments, where research shows topical cannabinoid-combined treatments are highly effective. Innocan went public on the Canadian Stock Exchange in 2020.